Brainsway Ltd (BWAY) - Total Liabilities

Latest as of September 2025: ILA43.00 Million ILA ≈ $115.27K USD

Based on the latest financial reports, Brainsway Ltd (BWAY) has total liabilities worth ILA43.00 Million ILA (≈ $115.27K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Brainsway Ltd (BWAY) long-term investment share to see how much of total assets are deployed in long-term investments.

Brainsway Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Brainsway Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Brainsway Ltd balance sheet assets.

Brainsway Ltd Competitors by Total Liabilities

The table below lists competitors of Brainsway Ltd ranked by their total liabilities.

Company Country Total Liabilities
PureTech Health PLC
NASDAQ:PRTC
USA $229.03 Million
Posiflex Technology Inc
TW:8114
Taiwan NT$6.51 Billion
Tangel Publishing
SHE:300148
China CN¥316.83 Million
Hangzhou Zhongya Machinery Co Ltd
SHE:300512
China CN¥1.05 Billion
Guangdong Huiyun Titanium Industry
SHE:300891
China CN¥1.83 Billion
Israel Land Development Company Co Ltd
TA:ILDC
Israel ILA7.45 Billion
Norma Group AG NA O.N.
XETRA:NOEJ
Germany €713.83 Million
Yunnan Yuntou Ecology and Environment Technology Co Ltd
SHE:002200
China CN¥1.31 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Brainsway Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Brainsway Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.19 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.61 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Brainsway Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Brainsway Ltd (2012–2024)

The table below shows the annual total liabilities of Brainsway Ltd from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 ILA32.00 Million
≈ $85.80K
+49.61%
2023-12-31 ILA21.39 Million
≈ $57.35K
+12.11%
2022-12-31 ILA19.08 Million
≈ $51.15K
+3.65%
2021-12-31 ILA18.41 Million
≈ $49.35K
+28.04%
2020-12-31 ILA14.38 Million
≈ $38.54K
-0.96%
2019-12-31 ILA14.52 Million
≈ $38.92K
-12.82%
2018-12-31 ILA16.65 Million
≈ $44.64K
+16.36%
2017-12-31 ILA14.31 Million
≈ $38.36K
+47.87%
2016-12-31 ILA9.68 Million
≈ $25.94K
+3.52%
2015-12-31 ILA9.35 Million
≈ $25.06K
-8.30%
2014-12-31 ILA10.19 Million
≈ $27.33K
+219.03%
2013-12-31 ILA3.20 Million
≈ $8.57K
+90.21%
2012-12-31 ILA1.68 Million
≈ $4.50K
--

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$422.69 Million
ILA157.66 Billion ILA
Market Cap Rank
#13157 Global
#139 in Israel
Share Price
ILA4020.00
Change (1 day)
-2.19%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more